Alkeon Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,464,021	Closed	-$41.5M	–	118
2025 Q3	$41.5M	Sell	5,464,021 -250,000	-4%	-$2.08M	0.19%	87
2025 Q2	$51.2M	Sell	5,714,021 -1,500,000	-21%	-$14M	0.25%	76
2025 Q1	$54.1M	Buy	7,214,021 +120,199	+2%	+$970K	0.32%	71
2024 Q4	$53.3M	Hold	7,093,822	–	–	0.31%	69
2024 Q3	$53.9M	Sell	7,093,822 -5,662	-0.1%	-$43K	0.3%	74
2024 Q2	$43.9M	Buy	7,099,484 +3,000,000	+73%	+$16.6M	0.22%	80
2024 Q1	$20.8M	Buy	4,099,484 +2,430,000	+146%	+$13.7M	0.11%	86
2023 Q4	$10M	Sell	1,669,484 -2,829	-0.2%	-$16.4K	0.07%	87
2023 Q3	$11.8M	Hold	1,672,313	–	–	0.07%	91
2023 Q2	$11.8M	Buy	1,672,313 +403,461	+32%	+$3.24M	0.07%	103
2023 Q1	$10.6M	Sell	1,268,852 -216,965	-15%	-$2.09M	0.07%	110
2022 Q4	$17.1M	Buy	1,485,817 +20,532	+1%	+$256K	0.13%	110
2022 Q3	$18.5M	Buy	1,465,285 +296,940	+25%	+$3.82M	0.13%	114
2022 Q2	$12.4M	Sell	1,168,345 -19,500	-2%	-$201K	0.07%	121
2022 Q1	$19.3M	Buy	+1,187,845	New	+$19.1M	0.09%	124